SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Iovance Biotherapeutics, Inc. – ‘10-Q’ for 6/30/20 – ‘XML’

On:  Thursday, 8/6/20, at 5:16pm ET   ·   For:  6/30/20   ·   Accession #:  1104659-20-91526   ·   File #:  1-36860

Previous ‘10-Q’:  ‘10-Q’ on 5/5/20 for 3/31/20   ·   Next:  ‘10-Q’ on 11/5/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 11/7/23 for 9/30/23   ·   9 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/06/20  Iovance Biotherapeutics, Inc.     10-Q        6/30/20   63:7.7M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.27M 
 2: EX-10.3     Material Contract                                   HTML     38K 
 3: EX-10.4     Material Contract                                   HTML     51K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     20K 
14: R1          Document And Entity Information                     HTML     71K 
15: R2          Condensed Consolidated Balance Sheets               HTML     90K 
16: R3          Condensed Consolidated Balance Sheets               HTML     40K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML     40K 
18: R5          Condensed Consolidated Statements of Comprehensive  HTML     29K 
                Loss                                                             
19: R6          Condensed Consolidated Statements of Stockholders'  HTML     80K 
                Equity                                                           
20: R7          Condensed Consolidated Statements of Cash Flows     HTML     84K 
21: R8          General Organization and Business                   HTML     29K 
22: R9          Summary of Significant Accounting Policies          HTML    143K 
23: R10         Cash Equivalents and Short-Term Investments         HTML    108K 
24: R11         Balance Sheet Components                            HTML     37K 
25: R12         Stockholders' Equity                                HTML     30K 
26: R13         Stock Based Compensation                            HTML     71K 
27: R14         Licenses and Agreements                             HTML     38K 
28: R15         Legal Proceedings                                   HTML     37K 
29: R16         Leases                                              HTML    141K 
30: R17         Related Party Transactions                          HTML     22K 
31: R18         Subsequent Event                                    HTML     21K 
32: R19         Summary of Significant Accounting Policies          HTML    173K 
                (Policies)                                                       
33: R20         Summary of Significant Accounting Policies          HTML    127K 
                (Tables)                                                         
34: R21         Cash Equivalents and Short-Term Investments         HTML    108K 
                (Tables)                                                         
35: R22         Balance Sheet Components (Tables)                   HTML     36K 
36: R23         Stock Based Compensation (Tables)                   HTML     64K 
37: R24         Leases (Tables)                                     HTML    129K 
38: R25         General Organization and Business (Details)         HTML     44K 
39: R26         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash,  HTML     38K 
                Cash equivalents and Restricted Cash (Details)                   
40: R27         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Loss   HTML     28K 
                per share (Details)                                              
41: R28         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair   HTML     25K 
                value (Details)                                                  
42: R29         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     23K 
                Stock-based compensation expense (Details)                       
43: R30         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     23K 
                Stock-based compensation by instrument (Details)                 
44: R31         Cash Equivalents and Short-Term Investments         HTML     26K 
                (Details)                                                        
45: R32         Cash Equivalents and Short-Term Investments -       HTML     23K 
                Short-term investments (Details)                                 
46: R33         CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Cost  HTML     33K 
                and fair value (Details)                                         
47: R34         Balance Sheet Components (Details)                  HTML     34K 
48: R35         Stockholders' Equity (Details)                      HTML     90K 
49: R36         STOCK BASED COMPENSATION - Stock Options (Details)  HTML     59K 
50: R37         STOCK BASED COMPENSATION - Assumptions (Details)    HTML     31K 
51: R38         STOCK BASED COMPENSATION - Additional information   HTML    104K 
                (Details)                                                        
52: R39         Licenses and Agreements (Details)                   HTML     69K 
53: R40         Legal Proceedings (Details)                         HTML     51K 
54: R41         LEASES - Company's right-of-use asset and lease     HTML     28K 
                liabilities (Details)                                            
55: R42         LEASES - components of lease expenses (Details)     HTML     42K 
56: R43         LEASES - maturities of the Company's operating      HTML     45K 
                lease liabilities (Details)                                      
57: R44         LEASES - Additional information (Details)           HTML    142K 
58: R45         RELATED PARTY TRANSACTIONS - Additional             HTML     35K 
                information (Details)                                            
59: R46         Subsequent Event (Details)                          HTML     23K 
61: XML         IDEA XML File -- Filing Summary                      XML    106K 
13: XML         XBRL Instance -- iova-20200630x10q_htm               XML   1.90M 
60: EXCEL       IDEA Workbook of Financial Reports                  XLSX     88K 
 9: EX-101.CAL  XBRL Calculations -- iova-20200630_cal               XML    113K 
10: EX-101.DEF  XBRL Definitions -- iova-20200630_def                XML    491K 
11: EX-101.LAB  XBRL Labels -- iova-20200630_lab                     XML    881K 
12: EX-101.PRE  XBRL Presentations -- iova-20200630_pre              XML    744K 
 8: EX-101.SCH  XBRL Schema -- iova-20200630                         XSD    133K 
62: JSON        XBRL Instance as JSON Data -- MetaLinks              254±   388K 
63: ZIP         XBRL Zipped Folder -- 0001104659-20-091526-xbrl      Zip    351K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.20.2 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 246 </ContextCount>
<ElementCount> 320 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 69 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 6 </UnitCount>
<MyReports>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00090 - Document - Document And Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document And Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00100 - Statement - Condensed Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/StatementCondensedConsolidatedBalanceSheets </Role>
<ShortName> Condensed Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Condensed Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00200 - Statement - Condensed Consolidated Statements of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/StatementCondensedConsolidatedStatementsOfOperations </Role>
<ShortName> Condensed Consolidated Statements of Operations </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00300 - Statement - Condensed Consolidated Statements of Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss </Role>
<ShortName> Condensed Consolidated Statements of Comprehensive Loss </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00400 - Statement - Condensed Consolidated Statements of Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity </Role>
<ShortName> Condensed Consolidated Statements of Stockholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 00500 - Statement - Condensed Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/StatementCondensedConsolidatedStatementsOfCashFlows </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 10101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureGeneralOrganizationAndBusiness </Role>
<ShortName> GENERAL ORGANIZATION AND BUSINESS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPolicies </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 10301 - Disclosure - CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureCashEquivalentsAndShortTermInvestments </Role>
<ShortName> CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 10401 - Disclosure - BALANCE SHEET COMPONENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureBalanceSheetComponents </Role>
<ShortName> BALANCE SHEET COMPONENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 10501 - Disclosure - STOCKHOLDERS' EQUITY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureStockholdersEquity </Role>
<ShortName> STOCKHOLDERS' EQUITY </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 10601 - Disclosure - STOCK BASED COMPENSATION </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureStockBasedCompensation </Role>
<ShortName> STOCK BASED COMPENSATION </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 10701 - Disclosure - LICENSES AND AGREEMENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLicensesAndAgreements </Role>
<ShortName> LICENSES AND AGREEMENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 10801 - Disclosure - LEGAL PROCEEDINGS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLegalProceedings </Role>
<ShortName> LEGAL PROCEEDINGS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 10901 - Disclosure - LEASES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLeases </Role>
<ShortName> LEASES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 11001 - Disclosure - RELATED PARTY TRANSACTIONS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureRelatedPartyTransactions </Role>
<ShortName> RELATED PARTY TRANSACTIONS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 11101 - Disclosure - SUBSEQUENT EVENT </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSubsequentEvent </Role>
<ShortName> SUBSEQUENT EVENT </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 30303 - Disclosure - CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureCashEquivalentsAndShortTermInvestmentsTables </Role>
<ShortName> CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureCashEquivalentsAndShortTermInvestments </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 30403 - Disclosure - BALANCE SHEET COMPONENTS (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureBalanceSheetComponentsTables </Role>
<ShortName> BALANCE SHEET COMPONENTS (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureBalanceSheetComponents </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 30603 - Disclosure - STOCK BASED COMPENSATION (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureStockBasedCompensationTables </Role>
<ShortName> STOCK BASED COMPENSATION (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureStockBasedCompensation </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 30903 - Disclosure - LEASES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLeasesTables </Role>
<ShortName> LEASES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureLeases </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 40101 - Disclosure - GENERAL ORGANIZATION AND BUSINESS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureGeneralOrganizationAndBusinessDetails </Role>
<ShortName> GENERAL ORGANIZATION AND BUSINESS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureGeneralOrganizationAndBusiness </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash equivalents and Restricted Cash (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash, Cash equivalents and Restricted Cash (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Loss per share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesLossPerShareDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Loss per share (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 27 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair value (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesFairValueDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Fair value (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 40204 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based compensation expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesStockBasedCompensationExpenseDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based compensation expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 40205 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based compensation by instrument (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesStockBasedCompensationByInstrumentDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock-based compensation by instrument (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 40301 - Disclosure - CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureCashEquivalentsAndShortTermInvestmentsDetails </Role>
<ShortName> CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureCashEquivalentsAndShortTermInvestmentsTables </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 40302 - Disclosure - CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Short-term investments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureCashEquivalentsAndShortTermInvestmentsShortTermInvestmentsDetails </Role>
<ShortName> CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Short-term investments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 40303 - Disclosure - CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Cost and fair value (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureCashEquivalentsAndShortTermInvestmentsCostAndFairValueDetails </Role>
<ShortName> CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS - Cost and fair value (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 33 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 40401 - Disclosure - BALANCE SHEET COMPONENTS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureBalanceSheetComponentsDetails </Role>
<ShortName> BALANCE SHEET COMPONENTS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureBalanceSheetComponentsTables </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 40501 - Disclosure - STOCKHOLDERS' EQUITY (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureStockholdersEquityDetails </Role>
<ShortName> STOCKHOLDERS' EQUITY (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureStockholdersEquity </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 40601 - Disclosure - STOCK BASED COMPENSATION - Stock Options (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureStockBasedCompensationStockOptionsDetails </Role>
<ShortName> STOCK BASED COMPENSATION - Stock Options (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 36 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 40602 - Disclosure - STOCK BASED COMPENSATION - Assumptions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureStockBasedCompensationAssumptionsDetails </Role>
<ShortName> STOCK BASED COMPENSATION - Assumptions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 40603 - Disclosure - STOCK BASED COMPENSATION - Additional information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureStockBasedCompensationAdditionalInformationDetails </Role>
<ShortName> STOCK BASED COMPENSATION - Additional information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 40701 - Disclosure - LICENSES AND AGREEMENTS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLicensesAndAgreementsDetails </Role>
<ShortName> LICENSES AND AGREEMENTS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureLicensesAndAgreements </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 40801 - Disclosure - LEGAL PROCEEDINGS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLegalProceedingsDetails </Role>
<ShortName> LEGAL PROCEEDINGS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureLegalProceedings </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 40901 - Disclosure - LEASES - Company's right-of-use asset and lease liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLeasesCompanySRightOfUseAssetAndLeaseLiabilitiesDetails </Role>
<ShortName> LEASES - Company's right-of-use asset and lease liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 41 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 40902 - Disclosure - LEASES - components of lease expenses (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLeasesComponentsOfLeaseExpensesDetails </Role>
<ShortName> LEASES - components of lease expenses (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 40903 - Disclosure - LEASES - maturities of the Company's operating lease liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLeasesMaturitiesOfCompanySOperatingLeaseLiabilitiesDetails </Role>
<ShortName> LEASES - maturities of the Company's operating lease liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 40904 - Disclosure - LEASES - Additional information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureLeasesAdditionalInformationDetails </Role>
<ShortName> LEASES - Additional information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 44 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 41001 - Disclosure - RELATED PARTY TRANSACTIONS - Additional information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails </Role>
<ShortName> RELATED PARTY TRANSACTIONS - Additional information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="iova-20200630x10q.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 41101 - Disclosure - SUBSEQUENT EVENT (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://lbio.com/role/DisclosureSubsequentEventDetails </Role>
<ShortName> SUBSEQUENT EVENT (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://lbio.com/role/DisclosureSubsequentEvent </ParentRole>
<Position> 46 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="iova-20200630x10q.htm"> iova-20200630x10q.htm </File>
<File> iova-20200630.xsd </File>
<File> iova-20200630_cal.xml </File>
<File> iova-20200630_def.xml </File>
<File> iova-20200630_lab.xml </File>
<File> iova-20200630_pre.xml </File>
<File> iova-20200630xex10d3.htm </File>
<File> iova-20200630xex10d4.htm </File>
<File> iova-20200630xex31d1.htm </File>
<File> iova-20200630xex31d2.htm </File>
<File> iova-20200630xex32d1.htm </File>
<File> iova-20200630xex32d2.htm </File>
</InputFiles>
<SupplementalFiles>
<File> iova-20200630x10q002.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/us-gaap/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/srt/2019-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Iovance Biotherapeutics, Inc.     10-K       12/31/23   95:11M                                    Toppan Merrill Bridge/FA
 2/28/23  Iovance Biotherapeutics, Inc.     10-K       12/31/22   78:10M                                    Toppan Merrill Bridge/FA
 2/24/22  Iovance Biotherapeutics, Inc.     10-K       12/31/21   79:10M                                    Toppan Merrill Bridge/FA
 2/25/21  Iovance Biotherapeutics, Inc.     10-K       12/31/20   84:11M                                    Toppan Merrill Bridge/FA
 2/09/21  Iovance Biotherapeutics, Inc.     424B5                  1:799K                                   Toppan Merrill/FA
11/05/20  Iovance Biotherapeutics, Inc.     10-Q        9/30/20   62:7.8M                                   Toppan Merrill Bridge/FA

3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/09/20  Iovance Biotherapeutics, Inc.     8-K:5,9     6/08/20   12:480K                                   Toppan Merrill/FA
 5/27/20  Iovance Biotherapeutics, Inc.     8-K:5,8,9   5/27/20   12:508K                                   Toppan Merrill/FA
 2/25/20  Iovance Biotherapeutics, Inc.     10-K       12/31/19   88:11M                                    Toppan Merrill/FA
↑Top
Filing Submission 0001104659-20-091526   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 11:15:49.1am ET